Could this pill prevent Chemo-Related bleeding risks?

NCT ID NCT07286032

Recruiting now Disease control Sponsor: Jiangsu HengRui Medicine Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times

Summary

This study tests an experimental drug, hetrombopag, to see if it can safely raise platelet counts in cancer patients whose platelets drop too low after chemotherapy. About 150 adults with solid tumors (like lung, breast, or colon cancer) will receive either the drug or a placebo during their chemo cycles. The goal is to help patients complete their planned chemo without delays or needing rescue treatments for low platelets.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acquired thrombocytopenia chemotherapy-induced toxicity neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PATIENTS WITH CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA

Contacts and locations

Locations

AdventHealth Hematology and Oncology Denver Cypress Hematology and Oncology
NOT_YET_RECRUITING

Denver, Colorado, 80210, United States
Cancer and Blood Specialty Clinic
NOT_YET_RECRUITING

Los Alamitos, California, 90254, United States
Mid-Florida Hematology & Oncology Centers, P.A.
RECRUITING

Orange City, Florida, 32763, United States
Morristown Medical Center
NOT_YET_RECRUITING

Morristown, New Jersey, 07039, United States
New York Cancer and Blood Specialists One Oncology
NOT_YET_RECRUITING

Shirley, New York, 11967, United States
Oncology & Hematology Associates of West Broward
NOT_YET_RECRUITING

Coral Springs, Florida, 33065, United States
Springfield Clinic
NOT_YET_RECRUITING

Springfield, Illinois, 62702, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.